PATIENT SATISFACTION FOR LEVONORGESTREL INTRAUTERINE SYSTEM AND NORETHISTERONE FOR TREATMENT OF DYSFUNCTIONAL UTERINE BLEEDING
AbstractBackground: Dysfunctional uterine bleeding (DUB) is a common problem with complexmanagement. It can be quite harrowing for the physicians as in most instances they are unable topinpoint the cause of abnormal bleeding even after a thorough history and physical examination. Aimwas to compare patient satisfaction for Levonorgestrel intra uterine system (LNG-IUS) andNorethisterone for the treatment of Dysfunctional Uterine Bleeding (DUB). It is Descriptive case seriesconducted in Department Obstetrics and Gynaecology, Shifa International Hospital, Islamabad fromSeptember, 2011 to September, 2012. Methods: One hundred and nineteen (119) female patients ofreproductive age Group with DUB were selected by consecutive sampling. Informed written consentwas obtained. A structural patient satisfaction questionnaire (PSQ) was used to collect informationregarding age of patients, type of method used for treatment of DUB (Levonorgestrel orNorethisterone), treatment outcome in terms of patient satisfaction scale, and decrease in bleeding after6 months. Results: The mean age of the patients was 41.03±4.415 year ranging from 28–60 years. Themean parity of women in the study was 3.22±1.188 with a range of 1–7. The satisfaction level wassignificantly (p<0.05) greater (90% versus 20%) in Group A (levonorgesterol-releasing intrauterinesystem) as compared with Group B (Norethisterone). The blood loss was significantly (p<0.05)decreased in Group A (98%) as compared with Group B (80%). The preference of continuing themethod as well as recommendation to a friend was significantly greater in Group A as compared toGroup B. Conclusion: The levonorgesterol-releasing intrauterine system (LNG-IUS) is a better choiceas compared to Norethisterone, for treatment of DUB with 90% patients highly satisfied.Keywords: Levonorgestrel, Norethisterone, patient satisfaction, treatment outcome
Chuong CJ, Brenner PE. Management of abnormal uterine
bleeding. Am J Obstet Gynecol 1996;175:787–92.
Albers JR, Hull SK, Wesley MA. Abnormal uterine bleeding.
Am Fam Phys 2004;69:1915–26.
Goldstein SR. Menorrhagia and abnormal bleeding before the
menopause. Best Pract Res Clin Obstet Gynaecol
Kilbourn CL, Richards CS. Abnormal uterine bleeding.
Diagnostic considerations, management options. Postgrad Med
;109:137–8, 141–4, 147–50.
Bongers MY, Mol BW, Brolmann HA. Current treatment of
dysfunctional uterine bleeding. Maturitas 2004;47(3):159–74.
Marjoribanks J, Lethaby A, Farquhar C; Surgery versus medical
therapy for heavy menstrual bleeding. Cochrane Database Syst
Hockey J, Veema V, Panay N. The wider role of intrauterine
progestogens. In: Studd J. (Ed). Progress in obstetrics and
Gynaecology. 1st ed. London: Elsevier;2005.p.393–402.
Milsom I. A comparison of flurbiprofen, Tranexamic acid, and a
levonorgestrel-releasing intrauterine contraceptive device in the
treatment of idiopathic menorrhagia. Am J Obstet Gynecol
Gray R. The future of hysterectomy. BJOG 2005;112:133–9.
Hurskainen R, Teperi J, Rissanen P, Aalto A, Grenman S, Kivela
A, et al. Clinical outcomes and costs with the Levonorgestrelreleasing intrauterine system or hysterectomy for treatment of
menorrhagia. Randomized trial 5-year follow up. JAMA
NICE Guidance. Heavy menstrual bleeding. January 2007. URL:
Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy
menstrual bleeding. Cochrane Database Syst Rev
Coulter A, Peto V, Jenkinson C. Quality of life and patient
satisfaction following treatment for menorrhagia. Fam Pract
Barrington JA, Bowen samplings P. The LN IUS in the
management of hemorrhagic. BJOG 1997;104:614–6.
Goodman A. Abnormal genital tract bleeding. Clin Cornerstone
Apgar BS. Dysmenorrhea and dysfunctional uterine bleeding.
Prim Care 1997;24:161–78.
Progestins: Present and Future [editorial], J Steroid Bio Chem
Molec Biol 1996;59(5–6):357–63.
Andersson K, Rybo G. Levonorgestrel-releasing intrauterine
system in the treatment of menorrhagia. BJOG 1990;97:690–4.
Luukkainen T, Lähteenmäki P, Toivonen J. Levonorgestrelreleasing intrauterine system. Ann Med 1990;22:85–90.
Sowter M. New surgical treatments for menorrhagia. Lancet
Sowter M. Menorrhagia: the role of endometrial ablation. In:
Daya S, Harrison RF, Kempers RD (Eds). Advances in Fertility
and Reproductive Medicine: Proceedings of the 18th World
Congress on Fertility and Sterility. Amsterdam, The Netherlands:
Busfied RA, Farquhar CM, Sowter MC, Lethasy A, Sprecher M,
et al. A randomised trial comparing the LN-IUS and thermal
bloom ablation for heavy menstrual bleeding. BJOG
Chaudhri R, Rizvi F, Afzal M. Patient satisfaction of Depot
Medroxyprogesterone Acetate (dmpa-sc) injection as
contraceptive. J Coll Physicains Surg Pak 2010;60(7):536–40.